A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom

European Journal of Paediatric Neurology

Volumn 14, Issue 2, 2010, Pages 156-161

  Ki Pang, K ^a   de Sousa, Carlos ^b   Lang, Bethan ^c   Pike, Michael G ^d  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b Department of Neurology ^*  (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Dancing Eye Syndrome; Opsoclonus Myoclonus syndrome; Prospective study

Indexed keywords

IMMUNOGLOBULIN; STEROID; TUMOR ANTIGEN;

AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INFANT; MALE; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED KINGDOM;

ABDOMINAL NEOPLASMS; BRAIN NEOPLASMS; CATECHOLAMINES; CHILD, PRESCHOOL; DEGLUTITION DISORDERS; FEMALE; HUMANS; INCIDENCE; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEUROBLASTOMA; OPSOCLONUS-MYOCLONUS SYNDROME; PREVALENCE; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS;

EID: 75349104985     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2009.03.002     Document Type: Article

References (33)

1. Cushing H., and Wolbach S.B. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. American Journal of Pathology 3 (1927) 203-205
2. Kinsbourne M. Myoclonic encephalopathy of infants. Journal of Neurology, Neurosurgery & Psychiatry 25 (1962) 271-276
3. Raffaghello L., Conte M., De Grandis E., and Pistoia V. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. European Journal of Paediatric Neurology 13 3 (2009) 219-223
4. Wilson J. Neuroimmunology of dancing eye syndrome in children. Developmental Medicine & Child Neurology 48 8 (2006) 693-696
5. Connolly A.M., Pestronk A., Mehta S., Pranzatelli III M.R., and Noetzel M.J. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. Journal of Pediatrics 130 6 (1997) 878-884
6. Antunes N.L., Khakoo Y., Matthay K.K., et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. Journal of Pediatric Hematology/Oncology 22 4 (2000) 315-320
7. Korfei M., Fuhlhuber V., Schmidt-Woll T., et al. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. Journal of Neuroimmunology 170 1-2 (2005) 150-157
8. Blaes F., Fuhlhuber V., Korfei M., et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Annals of Neurology 58 2 (2005) 313-317
9. Pranzatelli M.R., Hyland K., Tate E.D., et al. Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin. Journal of Child Neurology 19 12 (2004) 919-924
10. Pranzatelli M.R., Travelstead A.L., Tate E.D., et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62 9 (2004) 1526-1532
11. Young C.A., MacKenzie J.M., Chadwick D.W., and Williams I.R. Opsoclonus-myoclonus syndrome: an autopsy study of three cases. European Journal of Medicine 2 4 (1993) 239-241
12. Bataller L., Graus F., Saiz A., and Vilchez J.J. Spanish Opsoclonus-Myoclonus Study G. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124 Pt 2 (2001) 437-443
13. Blaes F., Jauss M., Kraus J., et al. Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies. Journal of Neurology, Neurosurgery & Psychiatry 74 11 (2003) 1595-1596
14. Tate E.D., Allison T.J., Pranzatelli M.R., and Verhulst S.J. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. Journal of Pediatric Oncology Nursing 22 1 (2005) 8-19
15. Pranzatelli M.R., Tate E.D., Dukart W.S., et al. Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. Journal of Pediatrics 147 3 (2005) 372-378
16. Matthay K.K., Blaes F., Hero B., et al. Opsoclonus myoclonus syndrome in neuroblastoma: a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Letters 228 1-2 (2005) 275-282
17. Tabarki B., Palmer P., Lebon P., and Sebire G. Spontaneous recovery of opsoclonus-myoclonus syndrome caused by enterovirus infection. Journal of Neurology, Neurosurgery & Psychiatry 64 3 (1998) 406-407
18. Sheth R.D., Horwitz S.J., Aronoff S., Gingold M., and Bodensteiner J.B. Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. Journal of Child Neurology 10 4 (1995) 297-299
19. Kuban K.C., Ephros M.A., Freeman R.L., Laffell L.B., and Bresnan M.J. Syndrome of opsoclonus-myoclonus caused by Coxsackie B3 infection. Annals of Neurology 13 1 (1983) 69-71
20. Rivner M.H., Jay W.M., Green J.B., and Dyken P.R. Opsoclonus in Hemophilus influenzae meningitis. Neurology 32 6 (1982) 661-663
21. Altman A.J., and Baehner R.L. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer 37 2 (1976) 846-852
22. Cohn S.L., Salwen H., Herst C.V., et al. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus. Cancer 62 4 (1988) 723-726
23. Gambini C., Conte M., Bernini G., et al. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases. Virchows Archiv 442 6 (2003) 555-562
24. Rudnick E., Khakoo Y., Antunes N.L., et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Medical & Pediatric Oncology 36 6 (2001) 612-622
25. Hiyama E., Yokoyama T., Ichikawa T., et al. Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome. Cancer 74 6 (1994) 1821-1826
26. Cardesa-Salzmann T.M., Mora J., García Cazorla M.A., et al. Epstein-Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors. Pediatric Blood & Cancer 47 7 (2006) 964-967
27. Biasotti S., Garaventa A., Villavecchia G.P., et al. False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma. Medical & Pediatric Oncology 35 2 (2000) 153-155
28. Siegel M.J., Ishwaran H., Fletcher B.D., et al. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 223 1 (2002) 168-175
29. Koh P.S., Raffensperger J.G., Berry S., et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. Journal of Pediatrics 125 5 Pt 1 (1994) 712-716
30. Russo C., Cohn S.L., Petruzzi M.J., and de Alarcon P.A. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Medical & Pediatric Oncology 28 4 (1997) 284-288
31. Mitchell W.G., Davalos-Gonzalez Y., Brumm V.L., et al. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 109 1 (2002) 86-98
32. Hayward K., Jeremy R.J., Jenkins S., et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. Journal of Pediatrics 139 4 (2001) 552-559
33. Papero P.H., Pranzatelli M.R., Margolis L.J., et al. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome. Developmental Medicine & Child Neurology 37 10 (1995) 915-932